One (1) Category 1A CME Credit available for this course.


  1. Identify pre-transfusion considerations
  2. Enumerate the appropriate steps for safe transfusion and identify which products are indicated given the clinical setting 
  3. Describe post transfusion reactions


  1. Advances in medical knowledge
  2. Legislative, regulatory, or organizational changes affecting patient care


Shah A, Stanworth SJ, McKechnie S. Evidence and triggers for the transfusion of blood and blood products. Anaesthesia. 2015 Jan;70 Suppl 1:10-9, e3-5. [PubMed]

Pybus S, MacCormac A, Houghton A, Martlew V, Thachil J. Inappropriateness of fresh frozen plasma for abnormal coagulation tests. J R Coll Physicians Edinb. 2012;42(4):294-300. [PubMed]

Müller MC, Arbous MS, Spoelstra-de Man AM, Vink R, Karakus A, Straat M, Binnekade JM, de Jonge E, Vroom MB, Juffermans NP. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion. 2015 Jan;55(1):26-35; quiz 25. [PubMed]

Tran HA, Chunilal SD, Tran H. An update of consensus guidelines for warfarin reversal. Med J Aust. 2014 Feb 03;200(2):82. [PubMed]

Core Competencies: 2,3,4,5,6